Market Overview

Cyanotech Trades Lower After Reporting Q4 Losses

Share:

Cyanotech Corporation (NASDAQ: CYAN) reported fourth-quarter net sales of $30.2 million in fiscal 2019 compared to $34.1 million in 2018.

The company reported gross profit was $10.4 million with gross profit margin of 34.7%, compared to gross profit of $13.3 million and gross profit margin of 39.2%.

“The net loss this year was due substantially from forced water conservation efforts causing re-inoculation of our spirulina ponds, and errors in cultivation judgement and execution,” explains Gerald Cysewski, CEO of Cyanotech. “This left the company well short of spirulina inventory to meet customer demand in certain channels. We can report that spirulina production has now stabilized, and subsequent to our fiscal year end, customer orders have returned to a more normal pattern."

Cyanotech’s CFO Brian Orlopp explained the net sales decrease of 11.5% in 2019 compared with 2018 was driven by a 9.2% decrease in sales of the packaged Nutrex Hawaii products, and a 30.2% decrease in bulk sales.

Shares traded down 5.3% at $2.93 at time of publication.

Related Links:

Brookfield Infrastructure To Buy Genesee & Wyoming In $8.4B Deal

Applied Materials Will Acquire Kokusai Electric For $2.2B

Posted-In: Earnings News

 

Related Articles (CYAN)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Credit Suisse: United Therapeutics Becoming More Fundamentally Driven

Wedbush Stays On The Sidelines With Square, Points To Margin Expansion Concerns